Virginia Retirement Systems’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Buy
102,850
+11,000
+12% +$35.4K ﹤0.01% 1071
2026
Q1
$265K Buy
91,850
+14,500
+19% +$57.1K ﹤0.01% 865
2025
Q4
$315K Buy
+77,350
New +$346K ﹤0.01% 838
2023
Q3
Sell
-14,000
Closed -$83.4K 1023
2023
Q2
$83.4K Buy
14,000
+900
+7% +$5.19K ﹤0.01% 956
2023
Q1
$42.8K Buy
+13,100
New +$52.3K ﹤0.01% 1022

Other funds holding SANA

Virginia Retirement Systems's SANA Position: Q2 2026 in Review

Virginia Retirement Systems increased its Sana Biotechnology (SANA) stake by 12% in Q2 2026, buying an estimated $35.4K and bringing the position to 102,850 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Virginia Retirement Systems first reported a position in SANA in Q1 2023 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Virginia Retirement Systems held 102,850 shares of Sana Biotechnology worth $359K as of Q2 2026.
  • Virginia Retirement Systems bought 11,000 Sana Biotechnology shares in Q2 2026, an estimated $35.4K.
  • Sana Biotechnology made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1071 holding.
  • Virginia Retirement Systems first reported a position in Sana Biotechnology in Q1 2023 and has held it in 5 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.